These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 37491594)

  • 1. Pyroptosis in neurodegenerative diseases: from bench to bedside.
    Wu KJ; Wang WR; Cheng QH; Li H; Yan WZ; Zhou FR; Zhang RJ
    Cell Biol Toxicol; 2023 Dec; 39(6):2467-2499. PubMed ID: 37491594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
    Wang S; Yuan YH; Chen NH; Wang HB
    Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases.
    Han YH; Liu XD; Jin MH; Sun HN; Kwon T
    Inflamm Res; 2023 Sep; 72(9):1839-1859. PubMed ID: 37725102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synopsis on Managment Strategies for Neurodegenerative Disorders: Challenges from Bench to Bedside in Successful Drug Discovery and Development.
    Bhat SA; Kamal MA; Yarla NS; Ashraf GM
    Curr Top Med Chem; 2017; 17(12):1371-1378. PubMed ID: 28017151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of basket trials in drug development for neurodegenerative disorders.
    Cummings J; Montes A; Kamboj S; Cacho JF
    Alzheimers Res Ther; 2022 May; 14(1):73. PubMed ID: 35614479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradigms and Success Stories of Natural Products in Drug Discovery Against Neurodegenerative Disorders (NDDs).
    Singh S; Chib S; Akhtar MJ; Kumar B; Chawla PA; Bhatia R
    Curr Neuropharmacol; 2024; 22(6):992-1015. PubMed ID: 36606589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Small Molecule-Based Medicinal Chemistry Approaches for Neurodegeneration Therapeutics.
    Sanghai N; Vuong B; Burak Berk A; Afridi MSK; Tranmer GK
    ChemMedChem; 2024 May; 19(9):e202300705. PubMed ID: 38329887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases.
    Bai X; Bian Z; Zhang M
    Phytomedicine; 2023 Jan; 109():154582. PubMed ID: 36610130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases.
    Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
    Biomed Pharmacother; 2021 Jun; 138():111428. PubMed ID: 33667787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders.
    Zilberter Y; Tabuena DR; Zilberter M
    Prog Neurobiol; 2023 Dec; 231():102539. PubMed ID: 37838279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of microRNA-485 in neurodegenerative diseases.
    Ryu IS; Kim DH; Cho HJ; Ryu JH
    Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug repurposing for neurodegenerative diseases.
    Shukla H; John D; Banerjee S; Tiwari AK
    Prog Mol Biol Transl Sci; 2024; 207():249-319. PubMed ID: 38942541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target.
    Yang YN; Zhang MQ; Yu FL; Han B; Bao MY; Yan-He ; Li X; Zhang Y
    Biochem Pharmacol; 2023 Sep; 215():115717. PubMed ID: 37516277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids.
    Kooshki L; Zarneshan SN; Fakhri S; Moradi SZ; Echeverria J
    Phytomedicine; 2023 Apr; 112():154686. PubMed ID: 36804755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease.
    Zhang M; He Q; Chen G; Li PA
    Neurodegener Dis; 2020; 20(2-3):73-83. PubMed ID: 33176317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases.
    Beura SK; Dhapola R; Panigrahi AR; Yadav P; Kumar R; Reddy DH; Singh SK
    Med Res Rev; 2023 Nov; 43(6):1835-1877. PubMed ID: 37132460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine.
    Jin S; Zhang L; Wang L
    Biomed Pharmacother; 2023 Sep; 165():115215. PubMed ID: 37494786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functions and dysfunctions of oligodendrocytes in neurodegenerative diseases.
    Han S; Gim Y; Jang EH; Hur EM
    Front Cell Neurosci; 2022; 16():1083159. PubMed ID: 36605616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases.
    Sataer X; Qifeng Z; Yingying Z; Chunhua H; Bingzhenga F; Zhiran X; Wanli L; Yuwei Y; Shuangfeng C; Lingling W; Hongri H; Jibing C; Xiaoping R; Hongjun G
    Neurol Res; 2023 Mar; 45(3):191-199. PubMed ID: 36184105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders.
    Almikhlafi MA; Karami MM; Jana A; Alqurashi TM; Majrashi M; Alghamdi BS; Ashraf GM
    Curr Neuropharmacol; 2023; 21(5):1165-1183. PubMed ID: 36043795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.